We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genetic Clue to Irritable Bowel Syndrome Found

By LabMedica International staff writers
Posted on 03 Apr 2014
Irritable bowel syndrome (IBS) may be caused by genetics, diet, past trauma, anxiety and all are thought to play a role, but now, for the first time, a defined genetic defect that causes a subset of IBS has been reported. More...


IBS is a common disorder that affects the large intestine and most patients with the disorder commonly experience symptoms of cramping, abdominal pain, bloating gas, diarrhea and constipation and most treatments for IBS target these symptoms. One of the risk factors for IBS is a family history of the syndrome where those who have a first-degree relative, such as a parent or sibling, with IBS are at increased risk of the condition.

An international team of scientists led by those at the Mayo Clinic (Rochester, MN, USA) studied the sodium channel of people with IBS and control subjects. Many of the patients with cardiac arrhythmias which are caused by mutations in the gene sodium channel, voltage-gated, type V, alpha subunit (SCN5A) also have symptoms of IBS. The team investigated whether patients with IBS have SCN5A variants that affect the function of the sodium ion channel protein Nav1.5.

The investigators performed genotype analysis of SCN5A in 584 persons with IBS and 1,380 control subjects. Mutant forms of SCN5A were expressed in Human Embryonic Kidney (HEK)-293 cells, and functions were assessed by voltage clamp analysis. A genome-wide association study (GWAS) was analyzed for an association signal for the SCN5A gene and replicated in 1,745 patients in four independent cohorts of IBS patients and controls.

Missense mutations were found in SCN5A in 13/584 patients (2.2%). Diarrhea-predominant IBS (IBS-D) was the most prevalent form of IBS in the overall study population (25%). However, a significantly greater percentage of individuals with SCN5A mutations had constipation-predominant IBS (IBS-C, 31%) than IBS-D (10%). In the GWAS and four replicated studies, the SCN5A locus was strongly associated with IBS.

The scientists were able to restore function to a patient with constipation predominant IBS with a defective SCN5A gene and resulting abnormally functioning sodium channel. They used a drug called mexiletine, which restored the function of the channel and reversed the patient's symptoms of constipation and abdominal pain. Gianrico Farrugia, MD, a lead study author, said, “This gives us hope that from only treating symptoms of the disease, we can now work to find disease-modifying agents, which is where we really want to be to affect long-term treatment of IBS.” The study was published on March 5, 2014, in the journal Gastroenterology.

Related Links:

Mayo Clinic



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.